More ‘science fiction’ in store as Moderna grows up

It’s less than two years since Moderna brought its coronavirus vaccine to the world, but the company’s global chief executive Stephane Bancel is already turning his mind to another medical mystery: cancer. The boss of the $US51 billion ($81.3 billion) Boston-based biotech, which emerged from relative obscurity in 2020 to become one of the best-known […]